A child with suspected toxic epidermal necrolysis presents with fever and widespread blistering. What is the appropriate management?

A child with suspected toxic epidermal necrolysis presents with fever and widespread blistering. What is the appropriate management?

• A. Prescribe systemic antihistamines and antimicrobial medications as prophylaxis
• B. Recommend analgesics, cool compresses, and oral antihistamines for comfort
• C. Consult with a pediatric intensivist for admission to a pediatric intensive care unit
• D. Order oral acyclovir 20 mg/kg/day in two doses for 6 to 12 months

Answer: (C)

Toxic epidermal necrolysis in a child is a life-threatening emergency that behaves like extensive burns. The main approach is to provide intensive supportive care in an ICU setting, with a pediatric intensivist coordinating transfer to a pediatric ICU for close monitoring and specialized treatment. This level of care is needed because large areas of skin loss lead to massive fluid and electrolyte shifts, temperature loss, high infection risk, and the need for meticulous wound care, pain control, nutrition, and prevention of complications. Early ICU admission allows aggressive fluid resuscitation, accurate electrolyte management, strict infection control, proper wound dressings similar to burn care, and vigilant monitoring of airway, breathing, and circulation. In this context, arranging transfer to the PICU ensures the child receives the multidisciplinary, resource-intensive care required for TEN. Comfort-focused measures like analgesia and cool compresses are insufficient on their own, and routine outpatient or non-ICU care would miss the critical needs of fluid balance, infection prevention, and wound management. Antiviral therapy such as long-term acyclovir is not indicated as a standard treatment for TEN, and prophylactic antimicrobials or antihistamines do not address the life-threatening systemic nature of the condition.

Toxic epidermal necrolysis in a child is a life-threatening emergency that behaves like extensive burns. The main approach is to provide intensive supportive care in an ICU setting, with a pediatric intensivist coordinating transfer to a pediatric ICU for close monitoring and specialized treatment. This level of care is needed because large areas of skin loss lead to massive fluid and electrolyte shifts, temperature loss, high infection risk, and the need for meticulous wound care, pain control, nutrition, and prevention of complications. Early ICU admission allows aggressive fluid resuscitation, accurate electrolyte management, strict infection control, proper wound dressings similar to burn care, and vigilant monitoring of airway, breathing, and circulation. In this context, arranging transfer to the PICU ensures the child receives the multidisciplinary, resource-intensive care required for TEN.

Comfort-focused measures like analgesia and cool compresses are insufficient on their own, and routine outpatient or non-ICU care would miss the critical needs of fluid balance, infection prevention, and wound management. Antiviral therapy such as long-term acyclovir is not indicated as a standard treatment for TEN, and prophylactic antimicrobials or antihistamines do not address the life-threatening systemic nature of the condition.